Remove Blogging Remove Development Remove Press
article thumbnail

Should You Bother Targeting the Tech Blogs for Your PR Campaigns?

Both Sides of the Table

6 or 7 years ago when TechCrunch was at its peak market share (they are still strong but many more tech blogs have also popped up) there was a term for getting covered there called “the TechCrunch bounce.” It’s also important for recruiting, fund raising, business development and even company morale.

Blogging 309
article thumbnail

Entrepreneurshit. The Blog Post on What It’s Really Like.

Both Sides of the Table

But for some strange reason they make you file your progress on fund raising, which is the widely picked up by the press. I like to speak about this topic with first-time wantrapreneurs because if you read the tech press every day you’d get the impression that it all glamor. But it’s hard to know that from the press.

Blogging 420
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why Your Marketing Campaign Sucks

Both Sides of the Table

Ever notice how some companies tend to be in the press all the time and your big new product launch struggled for inches? Here’s what’s going through his/her head: Is this story “newsworthy” or am I being asked to publish a press release? ” Can you imagine that ever getting inches in the press?

Marketing 389
article thumbnail

Should Startups Announce Their Funding?

Both Sides of the Table

One of the advantages of blogging, using social media, public speaking, etc as a VC is that you get a more nuanced view of these shifts by watching your own successes and failures. But succinctly this press places a marker in the ground for your company. This is true on all of the major tech blogs. Funding is news.

Startup 355
article thumbnail

Getting Back Your Series A Mojo

Both Sides of the Table

Last year I wrote a blog post on entrepreneurs with a chip on their shoulders. My friend Seth Levine covered this well in his blog post on “ Handling Rejection ” which you should also read. I could link to a bunch of blog posts that come across this way but prefer not to single anybody out. Here’s the deal.

Startup 371
article thumbnail

Inhibrix Pulls In $40M to Press Ahead With Cancer Drug Clinical Trials

Xconomy

Inhibrx, developer of protein drugs targeting cancer and other diseases, has raised $40 million from the hedge fund Viking Global Investors as the biotech steers several programs through early-stage clinical trials. The La Jolla, CA-based company was founded in 2010 by Mark Lappe, Brendan Eckelman, and Quinn Deveraux.

Press 67
article thumbnail

Save Your Spin for Someone Who Cares

Both Sides of the Table

Entrepreneurs get so used to friends and family congratulating them on their press coverage that they forget sometimes that this isn’t real. Press doesn’t mean anything other than free advertising. Press coverage really matters – The good news – your press coverage really does matter.